Cso
Apr 2022 - Jun 2024
AeroLeads people directory · profile
Sean Stevens Email & Phone Number
Discovery Leader for Early Stage Biotech and Biopharma | Entrepreneur | Advisor | Investor
1 work email found
@kbio.com
1 phone found area 415
LinkedIn matched
✓ Verified July 2026
4 data sources
Profile completeness 86%
Role
Discovery Leader for Early Stage Biotech and Biopharma | Entrepreneur | Advisor | Investor
Location
Del Mar, California, United States
Who is Sean Stevens? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Sean Stevens is listed as Discovery Leader for Early Stage Biotech and Biopharma | Entrepreneur | Advisor | Investor based in Del Mar, California, United States. AeroLeads shows a work email signal at kbio.com, phone signal with area code 415, and a matched LinkedIn profile for Sean Stevens.
Sean Stevens previously worked as CSO at Kbio and Vice President at Lung Biotechnology Pbc. Sean Stevens holds Phd, Molecular Biology from University Of Pennsylvania.
Company email context
Email format at kbio.com
This section adds company-level context without repeating Sean Stevens's masked contact details.
*@kbio.com
68% confidence
AeroLeads found 1 current-domain work email signal for Sean Stevens. Compare company email patterns before reaching out.
Profile bio
About Sean Stevens
Sean Stevens is a Discovery Leader for Early Stage Biotech and Biopharma | Entrepreneur | Advisor | Investor.
Listed skills include Biotechnology, Immunology, Drug Discovery, Molecular Biology, and 16 others.
13 roles · 44 years
Sean Stevens work experience
A career timeline built from the work history available for this profile.
Vice President
Lung Biotechnology Pbc
Our mission is to simplify and democratize the treatment of lung disease, using biotechnology to design therapies for PAH and other fatal lung diseases.
Mar 2018 - Apr 2022
Mammalian Synthetic Biology
Synthetic Genomics is a privately-held company dedicated to developing and commercializing genomic-driven solutions to address a wide range of global challenges. The company is focused on several key commercialization programs including: developing new synthetic DNA products and technologies through its subsidiary, SGI-DNA; algae biofuels and new and improved food and nutritional products through its subsidiary Genovia Bio; and synthetically-derived vaccine development through Synthetic Genomic Vaccines Inc. (SGVI), a business unit co-founded with the J. Craig Venter Institute. The company is also developing clean water technologies using microbial fuel cells and is developing sustainable agricultural products through AgraCast, a company co-founded with Plenus S.A. de C.V.The Mammalian Synthetic Biology group at SGI is a cross-disciplinary R&D team utilizing cutting-edge sequencing and bioinformatics, and cellular and molecular biology technologies for large-scale genome engineering of mammalian cells. The proprietary technologies developed at SGI for DNA design and synthesis, and genome engineering enable the rapid and efficient modification of mammalian genomes to address critical unmet needs in the fields of medicine, pharmaceuticals and biotechnology.
2014 - Mar 2018
Vice President Research
Ablexis Llc
Ablexis, LLC is a biotechnology company dedicated to developing the AlivaMab Mouse technology, an innovative, next-generation platform for antibody drug discovery based on technology principles established by its subsidiary, Aliva Biopharmaceuticals, Inc. The AlivaMab Mouse platform will provide the foundation for the efficient discovery and development of the next wave of human therapeutic antibodies to treat human diseases. Ablexis intends to commercialize the AlivaMab Mouse platform through creative partnering strategies.
2010 - 2014
~4 yrs
Director
2009 - 2010
~1 yr
Associate Director-Technology Evaluation
2008 - 2009
~1 yr
Associate Director-Immunology
• Research and development of antibody therapeutics directed against immunological targets for the treatment of disease• Identification and investigation of strategic alliances with corporate and academic partners• Design and creation of large-scale modifications of the mouse genome; co-creator of the VelocImmune mouse for production of fully-human antibodies• Project coordinator-Gates Grand Challenges in Global Health; production of novel mouse models for the testing of human vaccines in collaboration with Dr. Richard Flavell (Yale) and Dr. Markus Manz (IRB Bellinzona)• Collaboration coordinator; organize and oversee collaborations with academic laboratories
2006 - 2008
~2 yrs
Senior Staff Scientist
2005 - 2006
~1 yr
Staff Scientist
2002 - 2004
~2 yrs
Scientist
2000 - 2001
~1 yr
Postdoctoral Fellow
1994 - 2000
~6 yrs
Summer Internship
Picatinny Arsenal-Vehicle Fired Munitions
1983 - 1986
~3 yrs
Summer Internship
Picatinny Arsenal-Vehicle Fired Munitions
1983 - 1985
~2 yrs
2 education records
Sean Stevens education
Phd, Molecular Biology
University Of Pennsylvania
Bs, Biology
Bucknell University
FAQ
Frequently asked questions about Sean Stevens
Quick answers generated from the profile data available on this page.
What is Sean Stevens's role at their current company?
Sean Stevens is listed as Discovery Leader for Early Stage Biotech and Biopharma | Entrepreneur | Advisor | Investor.
What is Sean Stevens's email address?
AeroLeads has found 1 work email signal at @kbio.com for Sean Stevens.
What is Sean Stevens's phone number?
AeroLeads has found 1 phone signal(s) with area code 415 for Sean Stevens.
Where is Sean Stevens based?
Sean Stevens is based in Del Mar, California, United States.
What companies has Sean Stevens worked for?
Sean Stevens has worked for Kbio, Lung Biotechnology Pbc, Synthetic Genomics, Ablexis Llc, and Anaptysbio.
How can I contact Sean Stevens?
You can use AeroLeads to view verified contact signals for Sean Stevens, including work email, phone, and LinkedIn data when available.
What schools did Sean Stevens attend?
Sean Stevens holds Phd, Molecular Biology from University Of Pennsylvania.
What skills is Sean Stevens known for?
Sean Stevens is listed with skills including Biotechnology, Immunology, Drug Discovery, Molecular Biology, Biopharmaceuticals, Antibodies, Vaccines, and Lifesciences.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial